A Phase I/II Study of GX15-070MS in Untreated CLL

Status:
Completed

Trial end date:
2006-01-01

Target enrollment:

Participant gender:

This protocol is being run to determine the best phase II dose and schedule of obatoclax in patients with previously untreated CLL.

Phase 1

Gemin X

Obatoclax